Lista de obras - Timo Joensuu - Dominio Público Uruguay

177Lu-PSMA-617 radioligand therapy for a patient with lymph node metastatic prostate cancer

artículo científico publicado en 2017

2-Weekly versus 3-weekly docetaxel to treat castration-resistant advanced prostate cancer: a randomised, phase 3 trial

artículo científico publicado en 2013

A phase I/II trial of gefitinib given concurrently with radiotherapy in patients with nonmetastatic prostate cancer

artículo científico publicado en 2009

Accuracy and precision of patient positioning for pelvic MR-only radiation therapy using digitally reconstructed radiographs

artículo científico publicado en 2018

Ad3-hTERT-E1A, a fully serotype 3 oncolytic adenovirus, in patients with chemotherapy refractory cancer

artículo científico publicado en 2012

Antiviral and antitumor T-cell immunity in patients treated with GM-CSF-coding oncolytic adenovirus

artículo científico publicado en 2013

Biodistribution Analysis of Oncolytic Adenoviruses in Patient Autopsy Samples Reveals Vascular Transduction of Noninjected Tumors and Tissues

artículo científico publicado en 2015

Case-control estimation of the impact of oncolytic adenovirus on the survival of patients with refractory solid tumors

artículo científico publicado en 2014

Chronic Activation of Innate Immunity Correlates With Poor Prognosis in Cancer Patients Treated With Oncolytic Adenovirus

artículo científico publicado en 2015

Comparison of granulocyte-macrophage colony-stimulating factor and sucralfate mouthwashes in the prevention of radiation-induced mucositis: a double-blind prospective randomized phase III study

artículo científico publicado en 2002

Cumulative absolute breast cancer risk for young women treated for Hodgkin lymphoma

artículo científico

Evaluation of Alpha-Therapy with Radium-223-Dichloride in Castration Resistant Metastatic Prostate Cancer-the Role of Gamma Scintigraphy in Dosimetry and Pharmacokinetics

artículo científico publicado en 2015

Fc-gamma receptor polymorphisms as predictive and prognostic factors in patients receiving oncolytic adenovirus treatment

artículo científico publicado en 2013

Gene expression analysis of tumors demonstrates an induction of Th1 type immune response following intratumoral administration of ONCOS-102 in refractory solid tumor patients

artículo científico publicado en 2014

Immunological data from cancer patients treated with Ad5/3-E2F-Δ24-GMCSF suggests utility for tumor immunotherapy ⬇️

artículo científico publicado en 2015

Immunological effects of low-dose cyclophosphamide in cancer patients treated with oncolytic adenovirus

artículo científico publicado en 2011

Impact of preoperative chemoradiotherapy on survival in patients with resectable pancreatic cancer

artículo científico publicado en 2007

In vivo and in vitro distribution of type 5 and fiber-modified oncolytic adenoviruses in human blood compartments

artículo científico publicado en 2011

Integrin targeted oncolytic adenoviruses Ad5-D24-RGD and Ad5-RGD-D24-GMCSF for treatment of patients with advanced chemotherapy refractory solid tumors

artículo científico publicado en 2011

Interleukin 8 activity influences the efficacy of adenoviral oncolytic immunotherapy in cancer patients

artículo científico publicado en 2018

Local immunotherapy with ONCOS-102 shapes harmful tumor associated CD68+ macrophages to become beneficial cells that correlate with increased overall survival

artículo científico publicado en 2015

Lu-PSMA radioligand therapy of predominant lymph node metastatic prostate cancer

article published in 2019

Lung cancer following chemotherapy and radiotherapy for Hodgkin's disease

artículo científico publicado en 2002

Multimodal Primary Treatment of Metastatic Prostate Cancer with Androgen Deprivation and Radiation

artículo científico publicado en 2016

Oncograms Visualize Factors Influencing Long-Term Survival of Cancer Patients Treated with Adenoviral Oncolytic Immunotherapy.

artículo científico publicado en 2018

Oncolytic adenovirus ICOVIR-7 in patients with advanced and refractory solid tumors

artículo científico publicado en 2010

Oncolytic adenovirus coding for granulocyte macrophage colony-stimulating factor induces antitumoral immunity in cancer patients

artículo científico publicado en 2010

Oncolytic adenovirus treatment of a patient with refractory neuroblastoma

artículo científico publicado en 2010

Oncolytic adenovirus with temozolomide induces autophagy and antitumor immune responses in cancer patients

artículo científico publicado en 2013

Oncolytic virotherapy for treatment of breast cancer, including triple-negative breast cancer

artículo científico publicado en 2015

PET/CT Dose Planning for Volumetric Modulated Arc Radiation Therapy (VMAT) -Comparison with Conventional Approach in Advanced Prostate Cancer Patients

artículo científico

Phase II prospective trial of gefitinib given concurrently with cisplatin and radiotherapy in patients with locally advanced head and neck cancer.

artículo científico publicado en 2010

Planning of External Beam Radiotherapy for Prostate Cancer Guided by PET/CT.

artículo científico

Predictive and Prognostic Clinical Variables in Cancer Patients Treated With Adenoviral Oncolytic Immunotherapy

artículo científico publicado en 2016

Preliminary clinical experience of trans-1-Amino-3-(18)F-fluorocyclobutanecarboxylic Acid (anti-(18)F-FACBC) PET/CT imaging in prostate cancer patients

artículo científico publicado en 2014

Radiotherapy Boost for the Dominant Intraprostatic Cancer Lesion-A Systematic Review and Meta-Analysis

artículo científico publicado en 2015

Radium-223-Dichloride in Castration Resistant Metastatic Prostate Cancer-Preliminary Results of the Response Evaluation Using F-18-Fluoride PET/CT

artículo científico publicado en 2015

Safety of glucocorticoids in cancer patients treated with oncolytic adenoviruses

artículo científico publicado en 2010

Second Cancers Among 40 576 Testicular Cancer Patients: Focus on Long-term Survivors

article

Second Malignant Neoplasms Among Long-Term Survivors of Hodgkin’s Disease: A Population-Based Evaluation Over 25 Years

article by Graça M. Dores et al published 15 August 2002 in Journal of Clinical Oncology

Serotype chimeric oncolytic adenovirus coding for GM-CSF for treatment of sarcoma in rodents and humans

artículo científico publicado en 2014

Serum HMGB1 is a predictive and prognostic biomarker for oncolytic immunotherapy

artículo científico publicado en 2015

Sodium iodide symporter SPECT imaging of a patient treated with oncolytic adenovirus Ad5/3-Δ24-hNIS

artículo científico publicado en 2011

Stereotactic radiotherapy of symptomatic circumscribed choroidal hemangiomas

artículo científico publicado en 2003

Switching the fiber knob of oncolytic adenoviruses to avoid neutralizing antibodies in human cancer patients

artículo científico publicado en 2011

The clinical impact of using complex molecular profiling strategies in routine oncology practice. ⬇️

artículo científico publicado en 2018

Treatment of cancer patients with a serotype 5/3 chimeric oncolytic adenovirus expressing GMCSF.

artículo científico publicado en 2010

Treatment of melanoma with a serotype 5/3 chimeric oncolytic adenovirus coding for GM-CSF: Results in vitro, in rodents and in humans

artículo científico publicado en 2015

Verapamil results in increased blood levels of oncolytic adenovirus in treatment of patients with advanced cancer

artículo científico publicado en 2011

Volumetric Modulated Arc Therapy Planning For Primary Prostate Cancer With Selective Intraprostatic Boost Determined By (18) f-Choline PET-CT: In Regard to Kuang et al.

artículo científico publicado en 2015

Volumetric-modulated arc therapy for a pelvic lymph node metastasis from prostate cancer: a case report

artículo científico publicado en 2013

[(18)F]-fluorodeoxyglucose positron emission tomography and computed tomography in response evaluation of oncolytic adenovirus treatments of patients with advanced cancer

artículo científico publicado en 2013

Lista de obras de Timo Joensuu

177Lu-PSMA-617 radioligand therapy for a patient with lymph node metastatic prostate cancer

2-Weekly versus 3-weekly docetaxel to treat castration-resistant advanced prostate cancer: a randomised, phase 3 trial

A phase I/II trial of gefitinib given concurrently with radiotherapy in patients with nonmetastatic prostate cancer

Accuracy and precision of patient positioning for pelvic MR-only radiation therapy using digitally reconstructed radiographs

Ad3-hTERT-E1A, a fully serotype 3 oncolytic adenovirus, in patients with chemotherapy refractory cancer

Antiviral and antitumor T-cell immunity in patients treated with GM-CSF-coding oncolytic adenovirus

Biodistribution Analysis of Oncolytic Adenoviruses in Patient Autopsy Samples Reveals Vascular Transduction of Noninjected Tumors and Tissues

Case-control estimation of the impact of oncolytic adenovirus on the survival of patients with refractory solid tumors

Chronic Activation of Innate Immunity Correlates With Poor Prognosis in Cancer Patients Treated With Oncolytic Adenovirus

Comparison of granulocyte-macrophage colony-stimulating factor and sucralfate mouthwashes in the prevention of radiation-induced mucositis: a double-blind prospective randomized phase III study

Cumulative absolute breast cancer risk for young women treated for Hodgkin lymphoma

Evaluation of Alpha-Therapy with Radium-223-Dichloride in Castration Resistant Metastatic Prostate Cancer-the Role of Gamma Scintigraphy in Dosimetry and Pharmacokinetics

Fc-gamma receptor polymorphisms as predictive and prognostic factors in patients receiving oncolytic adenovirus treatment

Gene expression analysis of tumors demonstrates an induction of Th1 type immune response following intratumoral administration of ONCOS-102 in refractory solid tumor patients

Immunological data from cancer patients treated with Ad5/3-E2F-Δ24-GMCSF suggests utility for tumor immunotherapy ⬇️

Immunological effects of low-dose cyclophosphamide in cancer patients treated with oncolytic adenovirus

Impact of preoperative chemoradiotherapy on survival in patients with resectable pancreatic cancer

In vivo and in vitro distribution of type 5 and fiber-modified oncolytic adenoviruses in human blood compartments

Integrin targeted oncolytic adenoviruses Ad5-D24-RGD and Ad5-RGD-D24-GMCSF for treatment of patients with advanced chemotherapy refractory solid tumors

Interleukin 8 activity influences the efficacy of adenoviral oncolytic immunotherapy in cancer patients

Local immunotherapy with ONCOS-102 shapes harmful tumor associated CD68+ macrophages to become beneficial cells that correlate with increased overall survival

Lu-PSMA radioligand therapy of predominant lymph node metastatic prostate cancer

Lung cancer following chemotherapy and radiotherapy for Hodgkin's disease

Multimodal Primary Treatment of Metastatic Prostate Cancer with Androgen Deprivation and Radiation

Oncograms Visualize Factors Influencing Long-Term Survival of Cancer Patients Treated with Adenoviral Oncolytic Immunotherapy.

Oncolytic adenovirus ICOVIR-7 in patients with advanced and refractory solid tumors

Oncolytic adenovirus coding for granulocyte macrophage colony-stimulating factor induces antitumoral immunity in cancer patients

Oncolytic adenovirus treatment of a patient with refractory neuroblastoma

Oncolytic adenovirus with temozolomide induces autophagy and antitumor immune responses in cancer patients

Oncolytic virotherapy for treatment of breast cancer, including triple-negative breast cancer

PET/CT Dose Planning for Volumetric Modulated Arc Radiation Therapy (VMAT) -Comparison with Conventional Approach in Advanced Prostate Cancer Patients

Phase II prospective trial of gefitinib given concurrently with cisplatin and radiotherapy in patients with locally advanced head and neck cancer.

Planning of External Beam Radiotherapy for Prostate Cancer Guided by PET/CT.

Predictive and Prognostic Clinical Variables in Cancer Patients Treated With Adenoviral Oncolytic Immunotherapy

Preliminary clinical experience of trans-1-Amino-3-(18)F-fluorocyclobutanecarboxylic Acid (anti-(18)F-FACBC) PET/CT imaging in prostate cancer patients

Radiotherapy Boost for the Dominant Intraprostatic Cancer Lesion-A Systematic Review and Meta-Analysis

Radium-223-Dichloride in Castration Resistant Metastatic Prostate Cancer-Preliminary Results of the Response Evaluation Using F-18-Fluoride PET/CT

Safety of glucocorticoids in cancer patients treated with oncolytic adenoviruses

Second Cancers Among 40 576 Testicular Cancer Patients: Focus on Long-term Survivors

Second Malignant Neoplasms Among Long-Term Survivors of Hodgkin’s Disease: A Population-Based Evaluation Over 25 Years

Serotype chimeric oncolytic adenovirus coding for GM-CSF for treatment of sarcoma in rodents and humans

Serum HMGB1 is a predictive and prognostic biomarker for oncolytic immunotherapy

Sodium iodide symporter SPECT imaging of a patient treated with oncolytic adenovirus Ad5/3-Δ24-hNIS

Stereotactic radiotherapy of symptomatic circumscribed choroidal hemangiomas

Switching the fiber knob of oncolytic adenoviruses to avoid neutralizing antibodies in human cancer patients

The clinical impact of using complex molecular profiling strategies in routine oncology practice. ⬇️

Treatment of cancer patients with a serotype 5/3 chimeric oncolytic adenovirus expressing GMCSF.

Treatment of melanoma with a serotype 5/3 chimeric oncolytic adenovirus coding for GM-CSF: Results in vitro, in rodents and in humans

Verapamil results in increased blood levels of oncolytic adenovirus in treatment of patients with advanced cancer

Volumetric Modulated Arc Therapy Planning For Primary Prostate Cancer With Selective Intraprostatic Boost Determined By (18) f-Choline PET-CT: In Regard to Kuang et al.

Volumetric-modulated arc therapy for a pelvic lymph node metastasis from prostate cancer: a case report

[(18)F]-fluorodeoxyglucose positron emission tomography and computed tomography in response evaluation of oncolytic adenovirus treatments of patients with advanced cancer